MacroGenics Statistics

Total Valuation

MacroGenics has a market cap or net worth of $232.07 million. The enterprise value is $136.42 million.

Market Cap	232.07M
Enterprise Value	136.42M

Important Dates

The next estimated earnings date is Tuesday, November 12, 2024, after market close.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

MacroGenics has 62.72 million shares outstanding. The number of shares has increased by 0.77% in one year.

Shares Outstanding	62.72M
Shares Change (YoY)	+0.77%
Shares Change (QoQ)	+0.60%
Owned by Insiders (%)	2.72%
Owned by Institutions (%)	81.72%
Float	51.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.87
Forward PS	2.50
PB Ratio	4.20
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	3.33
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.71, with a Debt / Equity ratio of 0.59.

Current Ratio	2.71
Quick Ratio	2.53
Debt / Equity	0.59
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-172.77

Financial Efficiency

Return on equity (ROE) is -118.91% and return on invested capital (ROIC) is -82.62%.

Return on Equity (ROE)	-118.91%
Return on Assets (ROA)	-48.54%
Return on Capital (ROIC)	-82.62%
Revenue Per Employee	$120,997
Profits Per Employee	-$402,277
Employee Count	339
Asset Turnover	0.16
Inventory Turnover	137.98

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -30.32% in the last 52 weeks. The beta is 2.08, so MacroGenics's price volatility has been higher than the market average.

Beta (5Y)	2.08
52-Week Price Change	-30.32%
50-Day Moving Average	3.55
200-Day Moving Average	8.71
Relative Strength Index (RSI)	50.79
Average Volume (20 Days)	543,754

Short Selling Information

The latest short interest is 5.37 million, so 8.55% of the outstanding shares have been sold short.

Short Interest	5.37M
Short Previous Month	5.53M
Short % of Shares Out	8.55%
Short % of Float	10.38%
Short Ratio (days to cover)	8.92

Income Statement

In the last 12 months, MacroGenics had revenue of $41.02 million and -$136.37 million in losses. Loss per share was -$2.19.

Revenue	41.02M
Gross Profit	-135.46M
Operating Income	-196.79M
Pretax Income	-136.37M
Net Income	-136.37M
EBITDA	-189.29M
EBIT	-196.79M
Loss Per Share	-$2.19

Full Income Statement

Balance Sheet

The company has $140.37 million in cash and $34.06 million in debt, giving a net cash position of $106.32 million or $1.70 per share.

Cash & Cash Equivalents	140.37M
Total Debt	34.06M
Net Cash	106.32M
Net Cash Per Share	$1.70
Equity (Book Value)	57.82M
Book Value Per Share	0.92
Working Capital	99.05M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$153.41 million and capital expenditures -$3.61 million, giving a free cash flow of -$157.02 million.

Operating Cash Flow	-153.41M
Capital Expenditures	-3.61M
Free Cash Flow	-157.02M
FCF Per Share	-$2.50

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-479.76%
Pretax Margin	-332.47%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-382.60%

Dividends & Yields

MacroGenics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.77%
Shareholder Yield	-0.77%
Earnings Yield	-56.18%
FCF Yield	-64.69%

Analyst Forecast

The average price target for MacroGenics is $8.89, which is 140.27% higher than the current price. The consensus rating is "Buy".

Price Target	$8.89
Price Target Difference	140.27%
Analyst Consensus	Buy
Analyst Count	12
Revenue Growth Forecast (5Y)	22.81%
EPS Growth Forecast (5Y)	59.92%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MacroGenics has an Altman Z-Score of -8.48. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.48
Piotroski F-Score	n/a